Atossa Therapeutics to participate in Cantor Fitzgerald Global Healthcare Conference

Atossa Therapeutics is set to participate in the Cantor Fitzgerald Global Healthcare Conference 2023. The company's CEO, Steven Quay, will engage in a fireside chat on September 28th at 9:10 A.M. ET in New York, NY, offering insights into the company's innovative medicines, particularly focused on breast cancer, addressing unmet needs in the field. View the webcast here: https://investors.atossatherapeutics.com.